Gamma Knife Market Size, Share & Trends Analysis Report By Indication (Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases), By Region, And Segment Forecasts, 2023-2030

Report
105 Pages
June 2023
Region: Global
Grand View Research
ID: 4396481

The global gamma knife market size is expected to reach USD 626.4 million by 2030, according to this report. It is expected to grow at a CAGR of 5.0% from 2023 to 2030. The increasing prevalence of cancer, brain tumors, and other neurological diseases, rising adoption of these instruments in surgery centers, growing preference for Minimally Invasive Surgeries (MIS), and technological advancements in the device are among few factors expected to drive the market.

Gamma knife therapy is used for the treatment of various brain and neurological disorders such as brain tumors, brain metastases, epilepsy, and arteriovenous malformations. Demand for these instruments in surgery centers is growing due to their various advantages such as safety, micro-precision, lack of postsurgical complications, and lack of incisions.

Technological advancements have improved precision in surgery. For instance, the up-gradation of Leksell Gamma Knife models U, B, C/4C, and Perfexion to Icon provided micro-precision in surgery and boosted the adoption of this device in surgery centers. According to reports published by Elekta AB, approximately 70,000 patients undergo gamma knife surgery each year. This number is expected to increase over the forecast period owing to the rising prevalence of target diseases and increasing preference for MIS.

In addition, the growing demand for MIS over open surgeries is one of the key factors responsible for increasing the adoption of this therapy. Gamma knife treatment procedure results in fewer traumas and faster recovery as compared to open surgeries. It helps reduce hospital stays, thus ensuring economic viability and reduction in medical expenses. Lack of incisions and post-surgical complications are key factors responsible for boosting the demand for minimally invasive surgeries.

Gamma Knife Market Report Highlights

Malignant tumors emerged as the largest indication segment in 2022. The functional disorders segment is anticipated to witness the fastest growth over the forecast period
The Asia Pacific held the largest revenue share in 2022 owing to the rising incidence of cancer, developments in healthcare infrastructure, and rapid economic development across major emerging economies
Elekta AB is the only player operating in this market since Gamma Knife is a patent-protected trademark product of the company

This product will be delivered within 1-3 business days.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Needle Length
1.1.3. Therapy
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Snapshot

Chapter 3. Gamma knife Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Gamma knife Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies

Chapter 4. Gamma Knife Market: Indication Estimates & Trend Analysis

4.1. Indication Market Share, 2022 & 2030
4.2. Segment Dashboard
4.3. Global Gamma Knife Market by Indication Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Malignant Tumors
4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Benign Tumors
4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. Vascular Disorders
4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.4. Functional Disorders
4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.5. Ocular
4.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Gamma Knife Market: Regional Estimates & Trend Analysis

5.1. Regional market share analysis, 2022 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2022
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
5.6. North America
5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.6.2. U.S.
5.6.2.1. Key country dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory framework
5.6.2.4. Reimbursement scenario
5.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
5.6.3. Canada
5.6.3.1. Key country dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory framework
5.6.3.4. Reimbursement scenario
5.6.3.5. Canada market estimates and forecasts, 2018 - 2030
5.7. Europe
5.7.1. UK
5.7.1.1. Key country dynamics
5.7.1.2. Competitive Scenario
5.7.1.3. Regulatory framework
5.7.1.4. Reimbursement scenario
5.7.1.5. UK market estimates and forecasts, 2018 - 2030
5.7.2. Germany
5.7.2.1. Key country dynamics
5.7.2.2. Competitive Scenario
5.7.2.3. Regulatory framework
5.7.2.4. Reimbursement scenario
5.7.2.5. Germany market estimates and forecasts, 2018 - 2030
5.7.3. France
5.7.3.1. Key country dynamics
5.7.3.2. Competitive Scenario
5.7.3.3. Regulatory framework
5.7.3.4. Reimbursement scenario
5.7.3.5. France market estimates and forecasts, 2018 - 2030
5.7.4. Italy
5.7.4.1. Key country dynamics
5.7.4.2. Competitive Scenario
5.7.4.3. Regulatory framework
5.7.4.4. Reimbursement scenario
5.7.4.5. Italy market estimates and forecasts, 2018 - 2030
5.7.5. Spain
5.7.5.1. Key country dynamics
5.7.5.2. Competitive Scenario
5.7.5.3. Regulatory framework
5.7.5.4. Reimbursement scenario
5.7.5.5. Spain market estimates and forecasts, 2018 - 2030
5.7.6. Denmark
5.7.6.1. Key country dynamics
5.7.6.2. Competitive Scenario
5.7.6.3. Regulatory framework
5.7.6.4. Reimbursement scenario
5.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
5.7.7. Sweden
5.7.7.1. Key country dynamics
5.7.7.2. Competitive Scenario
5.7.7.3. Regulatory framework
5.7.7.4. Reimbursement scenario
5.7.7.5. Market estimates and forecasts, 2018 - 2030
5.7.8. Norway
5.7.8.1. Key country dynamics
5.7.8.2. Competitive Scenario
5.7.8.3. Regulatory framework
5.7.8.4. Reimbursement scenario
5.7.8.5. Norway market estimates and forecasts, 2018 - 2030
5.8. Asia Pacific
5.8.1. Japan
5.8.1.1. Key country dynamics
5.8.1.2. Competitive Scenario
5.8.1.3. Regulatory framework
5.8.1.4. Reimbursement scenario
5.8.1.5. Japan market estimates and forecasts, 2018 - 2030
5.8.2. India
5.8.2.1. Key country dynamics
5.8.2.2. Competitive Scenario
5.8.2.3. Regulatory framework
5.8.2.4. Reimbursement scenario
5.8.2.5. India market estimates and forecasts, 2018 - 2030
5.8.3. China
5.8.3.1. Key country dynamics
5.8.3.2. Competitive Scenario
5.8.3.3. Regulatory framework
5.8.3.4. Reimbursement scenario
5.8.3.5. China market estimates and forecasts, 2018 - 2030
5.8.4. South Korea
5.8.4.1. Key country dynamics
5.8.4.2. Competitive Scenario
5.8.4.3. Regulatory framework
5.8.4.4. Reimbursement scenario
5.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
5.8.5. Australia
5.8.5.1. Key country dynamics
5.8.5.2. Competitive Scenario
5.8.5.3. Regulatory framework
5.8.5.4. Reimbursement scenario
5.8.5.5. Australia market estimates and forecasts, 2018 - 2030
5.8.6. Thailand
5.8.6.1. Key country dynamics
5.8.6.2. Competitive Scenario
5.8.6.3. Regulatory framework
5.8.6.4. Reimbursement scenario
5.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
5.9. Latin America
5.9.1. Brazil
5.9.1.1. Key country dynamics
5.9.1.2. Competitive Scenario
5.9.1.3. Regulatory framework
5.9.1.4. Reimbursement scenario
5.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
5.9.2. Mexico
5.9.2.1. Key country dynamics
5.9.2.2. Competitive Scenario
5.9.2.3. Regulatory framework
5.9.2.4. Reimbursement scenario
5.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
5.9.3. Argentina
5.9.3.1. Key country dynamics
5.9.3.2. Competitive Scenario
5.9.3.3. Regulatory framework
5.9.3.4. Reimbursement scenario
5.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
5.10. MEA
5.10.1. South Africa
5.10.1.1. Key country dynamics
5.10.1.2. Competitive Scenario
5.10.1.3. Regulatory framework
5.10.1.4. Reimbursement scenario
5.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
5.10.2. Saudi Arabia
5.10.2.1. Key country dynamics
5.10.2.2. Competitive Scenario
5.10.2.3. Regulatory framework
5.10.2.4. Reimbursement scenario
5.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
5.10.3. UAE
5.10.3.1. Key country dynamics
5.10.3.2. Competitive Scenario
5.10.3.3. Regulatory framework
5.10.3.4. Reimbursement scenario
5.10.3.5. UAE market estimates and forecasts, 2018 - 2030
5.10.4. Kuwait
5.10.4.1. Key country dynamics
5.10.4.2. Competitive Scenario
5.10.4.3. Regulatory framework
5.10.4.4. Reimbursement scenario
5.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. Elekta AB
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Huiheng Medical, Inc.
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Akesis Inc.
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives

List of Tables

Table 1: List of Abbreviation
Table 2: North America Gamma Knife market, by region, 2018-2030 (USD Million)
Table 3: North America Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 4: U.S. Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 5: Canada Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 6: Europe Gamma Knife market, by region, 2018-2030 (USD Million)
Table 7: Europe Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 8: U.K. Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 9: Germany Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 10: France Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 11: Italy Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 12: Spain Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 13: Denmark Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 14: Sweden Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 15: Norway Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 16: Asia Pacific Gamma Knife market, by region, 2018-2030 (USD Million)
Table 17: Asia Pacific Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 18: Japan Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 19: China Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 20: India Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 21: Australia Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 22: Thailand Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 23: South Korea Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 24: Latin America Gamma Knife market, by region, 2018-2030 (USD Million)
Table 25: Latin America Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 26: Brazil Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 27: Mexico Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 28: Argentina Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 29: Middle East and Africa Gamma Knife market, by region, 2018-2030 (USD Million)
Table 30: Middle East and Africa Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 31: South Africa Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 32: Saudi Arabia Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 33: UAE Gamma Knife market, by indication, 2018-2030 (USD Million)
Table 34: Kuwait Gamma Knife market, by indication, 2018-2030 (USD Million)

List of Figures

Fig. 1: Market research process
Fig. 2: Data triangulation techniques
Fig. 3: Primary research pattern
Fig. 4: Primary interviews in North America
Fig. 5: Primary interviews in Europe
Fig. 6: Primary interviews in APAC
Fig. 7: Primary interviews in Latin America
Fig. 8: Primary interviews in MEA
Fig. 9: Market research approaches
Fig. 10: Value-chain-based sizing & forecasting
Fig. 11: QFD modeling for market share assessment
Fig. 12: Market formulation & validation
Fig. 13: Gamma Knife market: market outlook
Fig. 14: Gamma Knife market competitive insights
Fig. 15: Parent market outlook
Fig. 16: Related/ancillary market outlook
Fig. 17: Gamma Knife market driver impact
Fig. 18: Gamma Knife market restraint impact
Fig. 19: Gamma Knife market strategic initiatives analysis
Fig. 20: Gamma Knife market: Indication movement analysis
Fig. 21: Gamma Knife market: Indication outlook and key takeaways
Fig. 22: Malignant tumors market estimates and forecast, 2018-2030
Fig. 23: Benign tumors market estimates and forecast, 2018-2030
Fig. 24: Vascular disorders market estimates and forecast, 2018-2030
Fig. 25: Functional disorders therapy market estimates and forecast, 2018-2030
Fig. 26: Ocular market estimates and forecast, 2018-2030
Fig. 27: Global Gamma Knife market: Regional movement analysis
Fig. 28: Global Gamma Knife market: Regional outlook and key takeaways
Fig. 29: Global market shares and leading players
Fig. 30: North America market share and leading players
Fig. 31: Europe market share and leading players
Fig. 32: Asia Pacific market share and leading players
Fig. 33: Latin America market share and leading players
Fig. 34: Middle East & Africa market share and leading players
Fig. 35: North America: SWOT
Fig. 36: Europe SWOT
Fig. 37: Asia Pacific SWOT
Fig. 38: Latin America SWOT
Fig. 39: MEA SWOT
Fig. 40: North America, by country
Fig. 41: North America
Fig. 42: North America market estimates and forecast, 2018-2030
Fig. 43: U.S.
Fig. 44: U.S. market estimates and forecast, 2018-2030
Fig. 45: Canada
Fig. 46: Canada market estimates and forecast, 2018-2030
Fig. 47: Europe
Fig. 48: Europe. market estimates and forecast, 2018-2030
Fig. 49: U.K.
Fig. 50: U.K. market estimates and forecast, 2018-2030
Fig. 51: Germany
Fig. 52: Germany market estimates and forecast, 2018-2030
Fig. 53: France
Fig. 54: France market estimates and forecast, 2018-2030
Fig. 55: Italy
Fig. 56: Italy market estimates and forecast, 2018-2030
Fig. 57: Spain
Fig. 58: Spain market estimates and forecast, 2018-2030
Fig. 59: Denmark
Fig. 60: Denmark market estimates and forecast, 2018-2030
Fig. 61: Sweden
Fig. 62: Sweden market estimates and forecast, 2018-2030
Fig. 63: Norway
Fig. 64: Norway market estimates and forecast, 2018-2030
Fig. 65: Asia Pacific
Fig. 66: Asia Pacific market estimates and forecast, 2018-2030
Fig. 67: Japan
Fig. 68: Japan market estimates and forecast, 2018-2030
Fig. 69: China
Fig. 70: China market estimates and forecast, 2018-2030
Fig. 71: India
Fig. 72: India market estimates and forecast, 2018-2030
Fig. 73: Australia
Fig. 74: Australia market estimates and forecast, 2018-2030
Fig. 75: Thailand
Fig. 76: Thailand market estimates and forecast, 2018-2030
Fig. 77: South Korea
Fig. 78: South Korea market estimates and forecast, 2018-2030
Fig. 79: Latin America
Fig. 80: Latin America market estimates and forecast, 2018-2030
Fig. 81: Brazil
Fig. 82: Brazil market estimates and forecast, 2018-2030
Fig. 83: Mexico
Fig. 84: Mexico market estimates and forecast, 2018-2030
Fig. 85: Argentina
Fig. 86: Argentina market estimates and forecast, 2018-2030
Fig. 87: Middle East and Africa
Fig. 88: Middle East and Africa market estimates and forecast, 2018-2030
Fig. 89: Saudi Arabia
Fig. 90: Saudi Arabia market estimates and forecast, 2018-2030
Fig. 91: South Africa
Fig. 92: South Africa market estimates and forecast, 2018-2030
Fig. 93: UAE
Fig. 94: UAE market estimates and forecast, 2018-2030
Fig. 95: Kuwait
Fig. 96: Kuwait market estimates and forecast, 2018-2030
Fig. 97: Participant categorization - Gamma Knife market
Fig. 98: Market share of key market players - Gamma Knife market

Companies Mentioned

Elekta AB
Huiheng Medical, Inc.
MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
Akesis Inc.
Varian Medical Systems

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	105
Published	June 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 424.7 Million
Forecasted Market Value ( USD ) by 2030	$ 626.4 Million
Compound Annual Growth Rate	5.0%
Regions Covered	Global
No. of Companies Mentioned	5

PURCHASE OPTIONS

Single User License PDF

1 - 5 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5753EUR$5,950USD£4,909GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6720EUR$6,950USD£5,734GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8654EUR$8,950USD£7,384GBP

Gamma Knife Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Gamma Knife Market by Indication (Benign Tumors, Functional Disorders, Malignant Tumors), Anatomy (Head, Neck), Application - Forecast 2024-2030

Gamma Knife - Global Strategic Business Report

Gamma Knife Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Gamma Knife Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)